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Introduction
The requirements for minimising microbial contamination in
pharmaceutical cleanrooms are in regulatory documents
published by authorities that include the European
Commission1 and the Food and Drug Administration in the
USA2. These authorities also suggest the use of risk
management and assessment techniques to identify and
control sources of microbial contamination3,4. The authors of
this article have described risk management methods for
products manufactured in cleanrooms5–7, and risk assessment
techniques to determine the relative importance of sources of
microbial contamination8,9. An overview and discussion of
other approaches is provided by Mollah et al. (2013)10.
Risk is defined11 as ‘the combination of the severity of
harm and the probability of occurrence of that harm’, and can
be calculated from Equation 1.
Equation 1
Degree of risk = severity of harm × probability of harm
The word ‘criticality’ is often used as a synonym for ‘severity
of harm’. ‘Severity of harm’ from microbial contaminants,
when applied to products manufactured in cleanrooms, can be
determined by the following risk factors. 
a. The concentration of source microbes. 
b. The area of the product exposed to airborne deposition or
surface contact.
c. The ease by which source microbes are dispersed,
transmitted and deposited into, or onto, a product.
The ‘probability of harm’ can be assessed by the frequency of
deposition, which is either the number of surface contacts, or
the time available for airborne deposition. 
Actual values of these risk factors are often not available
and surrogate descriptors, such as ‘high’, ‘medium’ and ‘low’,
etc. are utilised. Scores are then assigned to these descriptors,
and the scores combined in the best way to give an assessment
of the degree of risk of a source6,7.
The assignment of descriptors and scores to risk factors is
subjective, and assigned values are often difficult to align with
actual values. Also, the method of combining risk scores to
obtain the degree of risk from a source may not accurately
model the actual mechanisms of dispersion, transmission and
deposition of microbial contamination. In addition, the
mechanisms through air, surface contact and liquid are different,
and the associated risks are, therefore, not readily comparable.
Owing to these problems, inaccurate risk assessments are often
The degree of risk from microbial contamination of manufactured products by sources of
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completed, and it would be beneficial if a technique was
available to overcome such drawbacks. This would be
especially welcome if the risk assessment also calculated the
product’s contamination rate from various cleanroom
sources, and would be a useful advance in the management
of microbial contamination in cleanrooms.
Whyte and Eaton8 have provided equations to calculate
the exact amount of microbial contamination of a product
and demonstrated their use in risk assessment; this
approach is expanded in this article. This article deals with
airborne sources and the next article will consider sources
of surface contact and liquid contamination.
Calculation of airborne microbial
contamination of a product
Equation 2 has been derived by Whyte and Eaton8 to
calculate the number of microbe-carrying particles
(MCPs) deposited from air onto or into a product.
Equation 2
NMDA = c*a*sv*t
where, NMDA = number of MCPs deposited from air
onto a single product, c = concentration of microbes
in the air next to the product, a = area of product
exposed to microbial deposition, s
v
= settling velocity
through air of MCPs , t = time of airborne deposition.
It is important to ensure that the units of measurement are
consistent in the risk equations, and those used in
Equation 2 in this article are centimetres and seconds.
Airborne concentrations are usually given as number per
m3, but to align the concentrations with other risk factors,
number per cm3 is used.
The above NMDA is calculated from knowledge of the
MCP concentration next to the product. However, some
sources of airborne risk will be a distance away from the
product, and in these situations it is necessary to know the
proportion of MCPs transmitted to the area next to the
product. This proportion is known as the transfer
coefficient, which is the ratio of the concentration of
MCPs at the product to the concentration at the source.
This proportion is included in Equation 3.
Equation 3
NMDA = c*p*a*sv*t
where, p = proportion of MCPs that are transmitted
from a source to the area next to the product (transfer
coefficient).
The NMDA onto one product unit is calculated, and gives
the expected contamination rate of a product from a given
source. Its numerical value is usually well below 1 but, if
required, can be converted to a more conventional
contamination rate. For example, if the NMDA is 1 x 10-6,
the contamination rate of the product is 1 in 106, or 1 in a
million units.
Most of the values of risk factors, i.e. the variables
required to solve Equation 3, are known by cleanroom
users, or can be determined. However, the settling velocity
of MCPs falling through cleanroom air is not well known.
MCPs rarely occur in cleanroom air in a unicellular form,
but are found on skin or clothing detritus dispersed from
personnel. The MCPs have an average equivalent particle
diameter of about 12 μm12,13, and settle under the influence
of gravity at a velocity of about 0.46 cm/s14. It is assumed
that the area of the product exposed to airborne
contamination is the surface in the horizontal orientation.
However, should the exposed surface be at an angle, the
‘effective’ area for MCPs that deposit under the influence
of gravity will be reduced. It can be calculated by
multiplying the area by Cos σ, where σ is the angle that the
surface is to the horizontal.
Equation 3 uses the concentration of MCPs in a volume
of air, as determined by a microbial air sampler. However,
settle plates can be used to accurately and directly
measure the deposition rate of MCPs. If a settle plate is
used to sample air adjacent to product, its count can be
used to calculate the NMDA by proportioning and use of
Equation 4.
Equation 4
area of exposed time product
product exposed
NMDA =  settle plate count × 111111 × 111111
area of time settle 
settle plate plate exposed
However, because of the greater popularity of air samplers
in evaluating airborne microbial contamination, and
greater availability of counts, air sampler concentrations
are used in this article.
Description of cleanroom studied
A pharmaceutical cleanroom, where aseptic filling of vials
is carried out, is used to demonstrate the NMDA method.
The cleanroom is fictitious but typical of those
cleanrooms where aseptic filling of small batches of
pharmaceutical products is carried out in a unidirectional
airflow workstation, rather than in a restricted access
barrier system (RABS) or isolator. Increasing regulatory
expectations are leading to manufacturing facilities being
designed with such separative devices, but to illustrate the
wider application of the risk assessment method to a
variety of healthcare facilities, the following cleanroom
and manufacturing process is used as an example.
Vials with an internal neck area of 2 cm2 are aseptically
filled with 2 ml of an aqueous product solution and sealed
with sterile closures. This is carried out in batches of 4000,
which take about 4 hours to process.
1. The vials are heat sterilised in a depyrogenation tunnel
and conveyed into a vertical unidirectional airflow
(UDAF) workstation (EU Guideline to Good
Manufacturing Practice (GGMP) grade A), which is
known as the ‘filling workstation’, where they are
automatically filled and sealed by inserting a stopper.
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The average time the vial is open to airborne
contamination, i.e. between exiting from the
depyrogenation tunnel and being sealed, is 10 minutes
(600 s).
2. Vial closures (rubber stoppers) are held in a hopper
within the filling workstation, which has a capacity of
1000 closures, and is replenished every hour.
3. The air supply and extract system and the particle
removal efficiency of the supply air filters are fully
described in the relevant section of this article.
However, all terminal filtration of the supply air is by
H14 high-efficiency particulate air (HEPA) filters, as
rated according to EN 1822: 201215.
4. The filling workstation is situated in a non-
unidirectional airflow cleanroom (EU GGMP grade B)
which is known as the ‘filling cleanroom’. It is 10 m x
10 m x 3 m, i.e. 300 m3 in volume, and supplied with
3.33 m3/s of HEPA-filtered air, which is equivalent to
40 room air changes per hour.
5. Two people work in the filling cleanroom, with one of
these attending to the filling machine within the filling
workstation. Access into the filling workstation is
through plastic-strip curtains that hang down to just
above the floor.
6. Personnel wear cleanroom clothing consisting of a
woven one-piece polyester coverall with hood,
overboots, mask and goggles. Sterilised, latex, double
gloves are worn over disinfected hands. There are no
areas of exposed skin.
7. Hard surfaces, which do not come into contact with
product, vials or closures, are disinfected. Hard
surfaces, such as pipework that contact product, or
product-contacting surfaces, such as sterile closures,
closure’s hopper and track-ways, are sterilised.
8. Eight litres of aqueous solution of product is prepared
in an adjacent cleanroom (EU GGMP grade C) and
piped from the preparation vessel through a sterilised,
sterilising-grade filter, into the filling workstation. An
aseptic connection is made in the filling workstation
with the product filling equipment.
Sources of airborne contamination 
Figure 1 shows the airflow in the cleanroom under
consideration, and Figure 2 gives a risk diagram that shows
the various sources of airborne contamination, their control
measures, and routes of transfer to product. Personnel are
considered the prime source of microbial contamination in a
cleanroom and disperse MCPs into the air of both the filling
workstation and filling cleanroom. Airborne contamination
may also enter the filling workstation and cleanroom
through the HEPA supply filters, especially if they are
damaged.
Calculation of degree of risk to product
in cleanroom
The degree of risk from the sources shown in Figure 2 can
be determined by calculating the NMDA into, or onto, one
product vial. The NMDA is calculated by use of Equation 3,
using centimetres and seconds as the units of measurement.
Each variable in the equation, i.e. the risk factors, is
assigned a value that the authors consider ‘typical’ of the
cleanroom described. For simplicity, and because it is
peripheral and has a very small risk, the risk associated with
‘air within adjacent cleanrooms’, although included in
Figure 2, is not calculated.
When sampling air in an EU GGMP grade A zone,
only an occasional MCP is found, and most samples
have zero counts. Average concentrations are, therefore,
used, and calculated as the number of MCPs isolated
from the total volume of air sampled over numerous
consecutive operational periods. The average
concentration of airborne microbes is required for the
whole period when the product or closures are exposed










Figure 1. Airflow in a cleanroom.
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to microbial deposition. Microbial air sampling is often
carried out for one single period during manufacture
but, for the purposes of risk assessment, several samples
should be taken to provide an average of the whole
period of exposure, including periods when personnel
are not in attendance.
Degree of risk from airborne MCPs dispersed by
personnel within filling workstation
The average concentration of MCPs in the air of an EU
GGMP grade A filling workstation during manufacturing
depends on whether personnel work inside or from outside
the workstation, the number of personnel involved, their
time within the workstation, their activity, and type of
cleanroom clothing worn. An average value should be
ascertained over the whole of the manufacturing time. The
lowest average value at the filling point is likely to be about
1 x 10-4/m3 (1 x 10-10/cm3) but the average concentration in
our example is taken as 0.01/m3 (1 x 10-8/cm3). To calculate
the degree of risk to product from air in the filling
workstation, the values of the variables (risk factors), and
the solution of Equation 3, is considered as follows. 
1. Concentration of airborne MCPs (number/cm3):
An average concentration close to where vials are
exposed during filling and over the whole of the
manufacturing period is 0.01/m3 (1 x 10-8/cm3).
2. Transfer coefficient: The air is sampled adjacent
to the exposed vials, and, therefore, a transfer
coefficient is not necessary, and taken as 1.
3. Area of product exposed (cm2): The inner neck
area of the vial is 2 cm2.
4. Time of deposition (s): The time the vial is
exposed is 600 s. 
5. Settling velocity of MCPs through air (cm/s): As
discussed in the ‘Calculation of airborne microbial
contamination of a product’ section, the average
setting velocity of MCPs through the air and into
the vial is assumed to be 0.46 cm/s.
Using Equation 3, the NMDA can be calculated;
NMDA = c*p*a*t*s = 1 x 10-8*1*2*600*0.46 = 5.5 x 10-6
(by contact)
= prime source              = source = control method
Product
Container closures 
in hopper in filling 
workstation
Air within filling workstation

























Figure 2. Risk diagram showing airborne sources of microbial contamination, control methods, and routes of transfer to product.
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Degree of risk from airborne MCPs dispersed by
personnel within filling cleanroom
The concentration of airborne MCPs in an EU GGMP
grade B filling cleanroom during manufacturing is
dependent on the effectiveness of the cleanroom
ventilation system, the number and activity of
personnel, and type of cleanroom clothing worn.
Depending on these variables, the lowest average value
is usually about 1/m3 (1 x 10-6/cm3) but the average
concentration in our example is taken as 5/m3 (5 x
10-6/cm3). 
It is necessary to know what proportion of MCPs in
the filling cleanroom is transferred to product, i.e. the
transfer coefficient. The filling workstation has a plastic
curtain round its perimeter to minimise this transfer.
However, personnel who move between the filling room
and the filling workstation, or pass their arms through
the curtains, will cause filling cleanroom air to be
transferred into the filling workstation. Also, by working
round the product and disturbing the unidirectional
airflow, filling cleanroom air may be transferred to
product.
Ljungqvist and Reinmuller16 have measured the
proportion of airborne particles that are transmitted
from outside a unidirectional airflow workstation to
product when personnel work through the curtain and
around the workstation. Using this information, it is
assumed that the proportion transferred (transfer
coefficient) from the filling cleanroom is 1 x 10-4.
However, the time personnel spend in attending to
machinery in the filling workstation is about 10% of the
total time spent in the cleanroom. The time of airborne
deposition of MCPs sourced in the filling cleanroom is,
therefore, taken as 60s. The degree of risk to product
from air in the filling cleanroom is now determined as
follows.
Degree of risk from the filtered air supply
The previous two sections of this article have calculated
the NMDA of MCPs in the filling workstation and filling
cleanroom. These calculations considered the risk from
airborne MCPs dispersed by personnel working in these
areas. However, there is also a degree of risk from the
filtered air supply, and this is now considered. 
Calculating the penetration of MCPs through air filters
The concentration of MCPs after an air filter is calculated
by Equation 5.
1. Concentration of airborne MCPs (number/cm3):
The average concentration in the filling cleanroom
is taken as 5/m3 (5 x 10-6/cm3). 
2. Transfer coefficient: The proportion of MCPs in
the filling cleanroom transmitted to product is
assumed to be 1 x 10-4. 
3. Area of product exposed (cm2): The inner neck
area of the vial is 2 cm2.
4. Time of airborne deposition (s): The time a vial is
exposed to contamination originating in the filling
cleanroom is 60 s
5. Settling velocity of MCPs through air (cm/s): As
discussed in the ‘Calculation of airborne microbial
contamination of a product’ section, the average
velocity of MCPs settling through the air and into
the vials is 0.46 cm/s.
Using Equation 3, the NMDA can be calculated;

























Figure 3. Relationship between penetration of most penetrating particle size (MPPS) and MCPs through high efficiency filters.
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Equation 5
Concentration after filter = concentration before filter
× penetration through filter
Air filters are rated according to their removal efficiency,
which is usually given as a percentage, or to the
proportion of airborne contamination that penetrates the
filters. These two quantities are related in Equation 6.
Equation 6
Penetration = 1 – (removal efficiency/100)
The high efficiency filters used in cleanrooms are
classified by EN 1822: 200915, which uses the removal
efficiency of the filter’s most penetrating particle size
(MPPS) of about 0.3 µm. Because of their much larger
size, fewer MCPs penetrate HEPA filters, and this
relationship has been investigated17 and shown in Figure 3.
Calculating the MCP concentration in supply air
The design of a typical air ventilation system used in a
cleanroom is shown in Figure 4. Air is extracted from the
cleanroom, mixed with some fresh air, passed through an
air conditioning plant, and returned to the filling
cleanroom and workstation. Fresh air is added for the
health of the personnel, and to make up the total air supply
so that the cleanroom is continually pressurised. This
proportion of fresh air is about 0.1 of the total air supplied
to the cleanroom. 
Typically, fresh air is mixed with recirculated air and
filtered by a primary filter before being passed through the
air conditioning plant. The conditioned air is then filtered
by a secondary filter to extend the life of the terminal
filter, and reduce the contamination risk to the product,
should a terminal supply filter in the ceiling be damaged. 
The concentration of MCPs in the air supplied to both
the filling cleanroom and workstation can be calculated by
Equation 7. If necessary, this equation can be modified for
other designs of ventilation systems.
Equation 7
cS = (p1*cr + p2*cfA)*ηP*ηS*ηt
where;
cs is the MCP concentration supplied to the filling
cleanroom and workstation, 
cr is the MCP concentration in the filling cleanroom and
recirculated air, 
cfA is the MCP concentration in fresh air, 
p1 is the proportion of recirculated air in the total air
supply volume, 
p2 is the proportion of fresh air in the total air supply
volume,
ηP is the proportion of MCPs removed by the primary
filters 
ηS is the proportion of MCPs removed by the secondary
filters, 
ηt is the proportion of MCPs removed by the terminal
filters. 
Fresh air has an MCP concentration of about 50/m3, and
the concentration in the filling cleanroom is assumed to be
5/m3. The proportion of fresh air is 0.1 and, therefore, the
proportion of recirculated air is 0.9. The mixture of fresh
and recirculated air is filtered by primary filters, which are
E10 bag filters with a removal efficiency against the
MPPS of about 85% (penetration = 0.15) and, as given in
Figure 3, they have an MCP penetration of about 1 x 10-4.
The secondary filters are H13, with a removal efficiency
against the MPPS of 99.95%, and an MCP penetration of
about 1 x 10-7. The terminal H14 filters have a removal
















Figure 4. Typical cleanroom ventilation system.
58 W WhytE AnD t EAton
efficiency against the MPPS of 99.995%, and an MCP
penetration of about 1 x 10-8.
The airborne concentration of MCPs supplied to the
filling cleanroom and workstation is therefore:
CS = {(0.9*5 x 10-6) + (0.1*5 x 10-5)}*1 x 10-4*1 x 10-7
*1 x 10-8
= {(4.5 x 10-6) + (5 x 10-6)}*1 x 10-19
= 9.5 x 10-25
The concentration of airborne MCPs approaching and
passing through a leak in the terminal HEPA filters will be
required in later calculations. The air passing through the
leak is assumed to be unfiltered by the terminal filter and,
therefore, has the same concentration as the air supplied to
the terminal filters. This can be calculated in the manner
given in the previous paragraph, and is 9.5 x 10-17/m3.
Degree of risk from air supplied into filling
workstation by HEPA filters without leaks
If the filter system that supplies air into the filling
workstation has no leaks, the NMDA from the supply air
can be calculated as follows.
In some filling workstations, the air supply is not from the
air conditioning plant but drawn from the filling
cleanroom where the airborne concentrations of MCPs is
5/m3 (5 x 10-6/cm3). This air may be only filtered by the
H14 terminal filters, with an overall removal efficiency of
99.995% (penetration = 0.00005) against the MPPS, and,
therefore, a penetration of MCPs of about 1 x 10-8. Thus,
the airborne concentration of MCPs supplied by the
terminal H14 filters in the filling workstation, as
determined by Equation 5, is as follows:
1. Concentration of MCPs in air supply
(number/cm3): The filling workstation is supplied
by air from the air conditioning plant that uses
primary, secondary and terminal filters of the type
described in the previous section. The average
concentration of MCPs in the air supplied from the
terminal HEPA filters, without leaks, has been
calculated to be 9.5 x 10-25.
2. Transfer coefficient: Air from the terminal HEPA
filter in the filling workstation flows in a
unidirectional manner to product and the airborne
concentration at product is assumed to be the same
as at the filter face, and the transfer coefficient is 1.
3. Area of product exposed to microbial deposition
(cm2): The inner neck area of the vial is 2 cm2.
4. Time of deposition (s): The time the vial is
exposed is 600 s.
5. Settling velocity of MCPs through air (cm/s): As
discussed in the ‘Calculation of airborne microbial
contamination of a product’ section, the average
velocity of MCPs settling through air to vials is
0.46 cm/s.
Using Equation 3, the NMDA can be calculated;
NMDA = c*p*a*t*s = 9.5 x 10-25*1*2*600*0.46 = 
5.2 x 10-22
CS = 5 x 10-6*1 x 10-8 = 5 x 10-14
Using the same approach as in the box above, the NMDA is,
NMDA=  c*p*a*t*s = 5 x 10-14*1*2*600*0.46 = 
2.8 x 10-11
Degree of risk from air supplied into filling
workstation by HEPA filters with a leak
HEPA filters are routinely tested for leaks by generating
sub-micrometre particles before the filter and scanning the
filter’s supply face with a probe, so as to obtain the
particle penetration through the filter. Leaks are
considered to occur if the penetration of the particle
challenge is greater than 0.01%. 
The area of a leak is much smaller than the filter’s
supply face area, and as the airflow in the filling
workstation is unidirectional, leaking air may pass through
the filling workstation at sufficient distance away from the
product vials that no contamination occurs. However, the
leak may be directly above the vials, and this worst case
situation is considered. Such a filter leak is considered
when (a) air is supplied by the air conditioning plant or (b)
air is drawn into the filling workstation from the filling
cleanroom. A maximum leak of 100%, and a minimum of
0.01% are investigated in each of these situations. 
(a) Air supplied by the air conditioning plant 
A maximum leak of 100% in a terminal HEPA filter will
only occur after an exceptional amount of filter damage,
and it is assumed that the large hole made will allow the
unfiltered supply air to pass through it. The NMDA can be
calculated as follows.
1. Concentration of airborne MCPs (number/cm3):
The average MCP concentration passing through a
leak in the HEPA filter and into the cleanroom has
been calculated in the ‘Calculating the MCP
concentration in supply air’ section to be 9.5 x 10-
17/cm3.
2. Transfer coefficient: Air from the HEPA filter face
flows in a unidirectional manner, and the
concentration of MCPs at product is assumed to be
the same as at the filter face, and the transfer
coefficient is therefore 1.
3. Area of product exposed (cm2): The inner neck
area of the vial is 2 cm2
4. Time of airborne deposition (s): Although the
time the vial is exposed is 600 s, vials are on a
conveyor, and the time directly below a filter leak
is considered to be 10 s.
5. Settling velocity of MCPs through air (cm/s): As
discussed in the ‘Calculation of airborne microbial
contamination of a product’ section, the average
settling velocity of MCPs through the air and into
the vials is 0.46 cm/s.
Using Equation 3, the NMDA can be calculated;
NMDA = c*p*a*t* s  = 9.5 x 10-17*1*2 *10*0.46 = 
8.7 x 10-16
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A minimum leak is taken as 0.01%, and these leaks are
not usually an actual hole but broken fibres in the filter
media, or a thinning of the depth of fibres. MCPs are,
therefore, less likely to penetrate than the MPPS
particles. However, the actual penetration of MCPs in this
situation is unknown, and thus the worst condition is
assumed, where the penetration of MCPs is the same as
MPPS particles. It is also assumed that the filter leak is
directly above the vials. 
Therefore,
NMDA = c*p*a*t*s = (9.5 x 10-17*0.0001)*1*2*10*
0.46 = 8.7 x 10-20
(b) Air drawn from the filling cleanroom 
If the filling workstation draws its air from the EU GGMP
grade B filling cleanroom, the MCP concentration in the
air approaching the filter can be assumed to be the same as
in the filling cleanroom, which is 5/m3 (5 x 10-6/cm3). For
a maximum leak of 100% in the terminal HEPA filters, the
NMDA is,
NMDA = c*p*a*t*s = 5 x 10-6*1*2*10*0.46 = 
4.6 x 10-5
If the leak has a minimum penetration of 0.01%, the
NMDA is,
NMDA = c*p*a*t*s = (5 x 10-6*0.0001)*1*2*10 *
0.46 = 4.6 x 10-9
Degree of risk from air supply to filling cleanroom
The risk to product from the air within the filling
cleanroom has been considered in the ‘Degree of risk from
airborne MCPs dispersed by personnel within filling
cleanroom’ section. That section considers the airborne
MCPs dispersed by personnel, but there may also be a
contribution from the air supplied from the terminal HEPA
filters. This may occur in a filter system with full integrity,
or with a leak in the system. 
(a) Full-integrity filtration system
The degree of risk from fully filtered air supplied to the
filling cleanroom is calculated as follows.
1. Concentration of MCPs in airborne source
(number/cm3): The average concentration of
MCPs in the filling cleanroom attributed to the air
supply is the same concentration as coming from
the terminal air filters. Other MCPs in the air of the
filling cleanroom that are dispersed by personnel
are considered in the ‘Degree of risk from airborne
MCPs dispersed by personnel within filling
cleanroom’ section. The concentration from
terminal filters has been calculated in the
‘Calculating the MCP concentration in supply air’
section and is 9.5 x 10-25/cm3.
2. Transfer coefficient: The MCPs in the cleanroom
air must pass across the unidirectional airflow in
(b) Leak in terminal filter system
The risk to product from a 100% penetration leak in a HEPA
filter that supplies the filling cleanroom, is now considered. 
The volume of air that passes through a hole in the
filter system can be calculated by Bernoulli’s equation.
This requires knowledge of the area of the hole, the
pressure difference across the hole, and the density of the
air. The effect of the type of hole on the airflow volume is
accounted for by a coefficient of discharge.
2∆𝑝 0.5𝑄 = 𝐶𝐷.𝐴. [11 ]𝜌
where, Q = flow rate (m3/s), CD = discharge
coefficient, A = area (m2), Δp = pressure difference
(Pa), and 𝜌 = air density (kg/m3).
Using a pressure difference across a HEPA filter of 250
Pa, the area of a large hole in the filter media of 0.5 cm2, a
discharge coefficient of 0.7, and an air density of
1.225 kg/m3, the air volume passing through the hole can
be calculated to be 0.0007 m3/s.
The air leaking through the hole in the filter will enter
the filling cleanroom where it will mix with the rest of the
air supply that has been correctly filtered. The total
amount of air supplied to the filling cleanroom room is
3.33 m3/s, and the volume of air from the leak is
0.0007 m3/s. Therefore, 3.329 m3/s of correctly filtered air
will pass into the filling cleanroom. 
The concentration of MCPs in leaking air has
previously been shown to be 9.5 x 10-17/cm3 and in the
filtered air it is 9.5 x 10-25/cm3. The air from the leak will
mix in the filling cleanroom with the correctly-filtered air
supply, and exit the room. The average concentration in
the mixed air is obtained by proportioning the appropriate
concentration of MCPs with the volumes of filtered and
leaking air, is as follows:
Average MCP = (9.5×10-25*3.329) + (9.5 × 
concentration 10-17*0.0007) = 3.2 × 10-24 +
6.7 × 10-20  = 6.7 x 10-20/cm2
the filling workstation, to reach the product. The
proportion that does so has been discussed in the
‘Degree of risk from airborne MCPs dispersed by
personnel within filling cleanroom’ section, and
considered to be 1 x 10-4.
3. Area of product exposed (cm2): The inner neck
area of the vial is 2 cm2.
4. Time of deposition (s): The time the vial is
exposed to MCPs from filters is 600 s. 
5. Settling velocity of MCPs through air (cm/s): As
discussed in the the ‘Degree of risk from the
filtered air supply’ section, the velocity of MCPs
settling through the air and into vials can be
assumed to be 0.46 cm/s.
Using Equation 3, the NMDA can be calculated;
NMDA = c*p*a*t *s  = 9.5 x 10-25*1 x 10-4*2*600*0.46
= 5.2 x 10-26
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Using this MCP concentration, the NMDA can be
calculated as previously shown.
NMDA = c*p*a*t*s = 6.7 x 10-20*1 x 10-4*2*600*0.46
= 3.7 x 10-20
Degree of risk from airborne contamination of
closures in the hopper
The hopper that contains closures is located within the
filling workstation. If it is open to workstation air, MCPs
may deposit from air onto closures and could
subsequently be introduced into product. 
If the hopper is cone shaped, the surface area of
stoppers exposed to deposition of MCPs will diminish as
stoppers are used. To give an approximation of the
average area of closures exposed, the area is taken as half
the surface of the top of the closures in the full hopper.
The degree of risk to product of vial closures is now
calculated as follows.
1. Concentration of MCPs in the air
(number/cm3): The average MCP concentration
over the period that the closures are exposed to
airborne deposition is assumed to be the same as
that suggested in the ‘Degree of risk from airborne
MCPs dispersed by personnel within filling
workstation’ section for the concentration at the
filling location, and is 1 x 10-8/cm3.
2. Transfer coefficient: The concentration of MCPs
is measured adjacent to the hopper, and a transfer
coefficient is not necessary, or taken as 1.
3. Area of product exposed to deposition (cm2): The
diameter of the hopper opening is 50 cm, with an
associated surface area of 1964 cm2. The average
surface area exposed to airborne deposition is
therefore assumed to be half of this surface area,
i.e. 982 cm2.
4. Time of airborne deposition(s): The closures are
replenished 4 times throughout the 4-hour filling
operation. The time the closures are exposed to
airborne deposition is therefore 3600 s.
5. Settling velocity of MCPs through air (cm/s): As
discussed in the ‘Calculation of airborne microbial
contamination of a product’ section, the average
settling velocity of MCPs in the air and into vials is
0.46 cm/s.
Using Equation 3, the NMDA onto all closures in the
hopper is;
NMDA = c*p*a*t*p = 1 x 10-8*1*982*3600*0.46 = 
1.6 x 10-2
This contamination will be deposited onto some of the
1000 closures in the hopper. Also, when a closure is
inserted into a container, only about half of its area is in
the container, and half the MCPs are introduced.
Therefore, for one stopper, the NMDA can be calculated; 
NMDA = 1.6 x 10-2*1 x 10-3*0.5 = 8.1 x 10-6
Hoppers can also be used with air-tight lids to minimise
airborne contamination. However, when the lid is lifted
and closures added to the near-empty hopper, the general
air turbulence will cause most of the hopper air to be
exchanged for filling workstation air. Also, because of
higher activity of personnel during replenishment, and
greater exposure to air transmitted across the curtains, the
concentration of airborne MCPs round the hopper during
the period of replenishment will be higher than the
average taken over the whole of the manufacturing time,
and assumed to be 1 x 10-7.
The hopper has a height of 15 cm and radius of 25 cm,
and hence its volume (π. r2. h/3) is 9818 cm3. After the
closures have been added, and the hopper lid shut, the
number of MCPs sealed in the hopper are,
Number of MCPs sealed in hopper
= volume of air in hopper x concentration MCPs in air 
= 9818*1 x 10-7 = 9.8 x 10-4
As MCPs have an average deposition velocity of 0.46
cm/s and 3600 s to deposit, it is reasonable to assume that
most of the MCPs sealed in the hopper will deposit onto
some of the 1000 closures in the hopper. Also, when a
closure is inserted into a vial, only about half of its area is
in the container, and thus only half the MCPs are
introduced. Therefore, for one stopper, the NMDA can be
calculated to be,
NMDA = 9.8 x 10-4*1 x 10-3*0.5 = 4.9 x 10-7
Relative importance of sources of airborne
contamination 
Shown in Table 1 are the NMDA of sources of airborne
contamination found in the cleanroom used as an
example. The NMDA values are given in order of
importance.
Discussion and conclusions
The risk to a product from sources of airborne microbial
contamination in healthcare cleanrooms has been
assessed. This was carried out by calculating the number
of microbes deposited from air (NMDA) into, or onto, a
product. The NMDA was calculated by use of Equation 3,
which uses the following risk factors as variables:
concentration of source microbes; area of product
exposed to airborne deposition; the ease of microbial
dispersion; transmission and deposition from a source to
a product; time available for deposition to occur.
Equation 3 is a fundamental equation and if the values of
the risk factors are correct then the result will be exact.
There are other advantages to this method, as the
calculation of the degree of risk of sources is more
accurate than typical methods in use, and it also gives the
actual contamination rate of the product.
Many of the risk factors required to solve Equation 3
are available, or can be obtained. Even if this is not
possible, an informed assessment will lead to a more
accurate risk value than methods used at present. Much of
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the required information is not difficult to obtain, e.g.
average airborne concentration of MCPs, area of product
exposed to airborne deposition, deposition velocity, and
time product is exposed to contamination. However, the
ease of transfer of MCPs from source to product, as given
by transfer coefficients, may be missing. If this is so, then
values can be obtained by the method advocated by
Ljungqvist and Reinmuller16.
To demonstrate how the NMDA method can be used
in a wide variety of cleanroom situations, a
pharmaceutical cleanroom that uses a UDAF
workstation and small-batch aseptic filling is given as
an example, and the results summarised in Table 1. In
this example, the higher risks are associated with
personnel activities within the filling workstation, and
the highest of these is caused by airborne contamination
of vial closures within an open hopper, and subsequent
transfer to product (8.1 x 10-6). Use of a lidded hopper
reduces this risk by approximately 16-fold to 4.9 x 10-7.
The risk from deposition of MCPs dispersed by
personnel in the workstation is also high (5.5 x 10-6). If a
reduction in the levels of risk from personnel is
considered necessary, a review of the associated risk
factors will indicate where reductions can be best
achieved. In this case, it may be appropriate to reduce
the airborne concentration of MCPs by means of the use
of a separative device, such as a RABS or isolator.
Methods of managing risk in this situation, and in
situations with different ventilation and manufacturing
methods, will be considered more fully in the final
article of the series.
The degree of risk from air supplied by the terminal
HEPA filters in both the filling workstation and filling
cleanroom was assessed. When the terminal air filters
have no leaks, and the air conditioning plant supplies the
air, the contribution from the supply air presents the
lowest risk of product microbial contamination (<1 x
10-21) and the risk can be ignored. When there are no leaks
in the workstation’s supply filter system but the supply air
is drawn from the filling cleanroom, there is an increase in
the NMDA to 2.8 x 10-11.
Leaking filters were also assessed. The worst of these
scenarios occurs when there is a leak in the HEPA filter
directly above the product vials in the filling
workstation, and when the supply air is drawn directly
from the filling cleanroom and not the air conditioning
plant. When a 100% leak occurs in these conditions, this
gives the highest risk of product contamination (4.6 x
10-5). However, when air is supplied from the air
conditioning plant, the risk is substantially reduced by a
factor of approximately 1011 to an NMDA of 8.7 x 10-16,
which is caused by additional filtration in the air
conditioning system prior to the filter with a 100% leak.
A similar risk reduction for a HEPA filter with a 0.01%
leak can also be achieved if the air is sourced from the air
conditioning system. The risk of product contamination
from a leaking HEPA filter within the filling workstation
can, therefore, be effectively managed by using an
Table 1. Importance of sources of airborne microbial contamination in a pharmaceutical cleanroom.
Risk Source of airborne microbial contamination NMDA
importance
1 Filling workstation (EU GGMP grade A) filters – air drawn from filling cleanroom, 100% leak in filter 4.6 x 10-5
directly above vials
2 Closures hopper – closures in open hopper 8.1 x 10-6
3 Filling workstation (EU GGMP grade A) – MCPs generated by personnel working in workstation 5.5 x 10-6
4 Closures hopper – closures in lidded hopper 4.9 x 10-7
5 Filling cleanroom (EU GGMP grade B) – MCPs generated by personnel in room 2.8 x 10-8
6 Filling workstation (EU GGMP grade A) filters – air supply drawn from filling cleanroom, 0.01% 4.6 x 10-9
leak in filter directly above vials
7 Filling workstation (EU GGMP grade A) filters – air drawn from filling cleanroom, no leaks in filter 2.8 x 10-11
8 Filling workstation (EU GGMP grade A) filters – air supply from air conditioning plant, 100% leak 8.7 x 10-16
in filter directly above vials
9 Filling workstation (EU GGMP grade A) filters – air drawn from air conditioning plant, 0.01% leak 8.7 x 10-20
in filter directly above vials
10 Filling cleanroom (EU GGMP grade B) filters – air supply from air conditioning plant, 100% 3.7 x 10-20
leak in filter
11 Filling workstation (EU GGMP grade A) filters – air supply from air conditioning plant, no leak in filter 5.2 x 10-22
12 Filling cleanroom (EU GGMP grade B) filters – air supply from air conditioning plant, no leak in filter 5.2 x 10-26
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additional filter in the supply air.
This article only reports on the assessment of the
degree of risk from airborne sources, and risks from
surfaces and liquids will be considered in a second article.
A final paper will consider the risks from all microbial
sources in various types of healthcare cleanrooms, and
methods of managing these risks.
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